Robert Hüneburg (@rhuneburg) 's Twitter Profile
Robert Hüneburg

@rhuneburg

Gastroenterologist at the National Center for Hereditary Tumor Syndromes Germany. Focus on Lynch, adenomatous polyposis syndromes and hereditary gastric cancer

ID: 739183070620876800

calendar_today04-06-2016 19:52:32

664 Tweet

810 Followers

460 Following

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

This cohort study indicated that MMR/MSI testing for individuals with colorectal cancer increased markedly, suggesting increased NCCN guideline adherence. ja.ma/3CM6WNr

This cohort study indicated that MMR/MSI testing for individuals with colorectal cancer increased markedly, suggesting increased NCCN guideline adherence. ja.ma/3CM6WNr
CGA-IGC (@cgaigc) 's Twitter Profile Photo

Dana-Farber #LynchSyndrome Center is organizing the 2nd Annual Lynch Syndrome Scientific Symposium. Hosted by Matt Yurgelun, MD & Sapna Syngal, MD it includes many expert speakers. Proud to see so many #CGAIGC members involved inc Zsofia Stadler Timothy Yen MD Ajay Bansal & more

<a href="/DanaFarber/">Dana-Farber</a> #LynchSyndrome Center is organizing the 2nd Annual Lynch Syndrome Scientific Symposium. 

Hosted by <a href="/MattYurgelun/">Matt Yurgelun, MD</a> &amp; <a href="/SapnaSyngal/">Sapna Syngal, MD</a> it includes many expert speakers. Proud to see so many #CGAIGC members involved inc <a href="/StadlerZsofia/">Zsofia Stadler</a> <a href="/TimYen1/">Timothy Yen MD</a> <a href="/AjayBansal_KUMC/">Ajay Bansal</a> &amp; more
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Single-cycle of neoadj. pembrolizumab in stage I-III dMMR/MSI CRC #ASCOGI25 🔎Final analysis of RESET-C phs-2, 85 pts 👉pCR: 44%, mPR: 57% 👉higher pCR rate in stage I-II 👉No new safety signals 🧐amazing: a single cycle sufficed to achieve pCR in some pts > on the way to WW in

Single-cycle of neoadj. pembrolizumab in stage I-III dMMR/MSI CRC #ASCOGI25
🔎Final analysis of RESET-C phs-2, 85 pts
👉pCR: 44%, mPR: 57%
👉higher pCR rate in stage I-II
👉No new safety signals
🧐amazing: a single cycle sufficed to achieve pCR in some pts &gt; on the way to WW in
CGA-IGC (@cgaigc) 's Twitter Profile Photo

📢Interested in submitting an abstract for the Dana-Farber #LynchSyndrome Scientific Symposium❓ ➡️The abstract submission deadline has been EXTENDED‼️ ⏱️NOW February 12, 2025, at 11:59 EST 📍Submit your abstract here👉tinyurl.com/429ystbk ✅Register here 👉

📢Interested in submitting an abstract for the <a href="/DanaFarber/">Dana-Farber</a> #LynchSyndrome Scientific Symposium❓

➡️The abstract submission deadline has been EXTENDED‼️

⏱️NOW February 12, 2025, at 11:59 EST
📍Submit your abstract here👉tinyurl.com/429ystbk
✅Register here 👉
CGA-IGC (@cgaigc) 's Twitter Profile Photo

#ColorectalCancerAwarenessMonth starts on March 1 with #DressinBlueDay‼️ No matter what your role is in the #HereditaryGICancer community, wear blue & help raise awareness for everything related to #colorectalcancer‼️

#ColorectalCancerAwarenessMonth starts on March 1 with #DressinBlueDay‼️

No matter what your role is in the #HereditaryGICancer community, wear blue &amp; help raise awareness for everything related to #colorectalcancer‼️
Robert Hüneburg (@rhuneburg) 's Twitter Profile Photo

Neoplasia detection via colonic surveillance among young individuals with MSH6 and PMS2-associated Lynch Syndrome. pubmed.ncbi.nlm.nih.gov/40013688/

CGA-IGC (@cgaigc) 's Twitter Profile Photo

👍awareness campaign for #LynchSyndrome by our friends & colleagues from Germany. ➡️Many people around the 🌏are #LynchSyndrome carriers & don't know it! 📣#Healthcare professionals, empower your #patients & get them to learn their family's cancer history, & if there are red

Alexander Hann (@alexsworking) 's Twitter Profile Photo

Presenting a digital tool to detect & count adenomas in #FAP patients during colonoscopy. Using real-time eye-tracking & voice recognition for data annotation. Universität Würzburg #UniWürzburg #UKB Joel Troya Sebastian Robert Hüneburg Thanks to Wilhelm Sander-Stiftung for the funding!

Robert Hüneburg (@rhuneburg) 's Twitter Profile Photo

🚀 Patients 600, 601, and 602 enrolled! Today, we reached a new milestone in the CADLY2 trial, the largest randomized study to date comparing ADR in Lynch syndrome patients with and without the assistance of AI (CADe). CGA-IGC EHTGtweets cadly2.org #CADLY2 #Lynch

CGA-IGC (@cgaigc) 's Twitter Profile Photo

What fabulous news on the last day of #ColorectalCancerAwarenessMonth! Congratulations Robert Hüneburg et al for this achievement. I know you will reach your target of 764 patients! We eagerly await the results of this important study! #HereditaryGICancer #LynchSyndrome

Matt Yurgelun, MD (@mattyurgelun) 's Twitter Profile Photo

There’s still time to join us for our Dana-Farber #LynchSyndrome Scientific Symposium all day Wed April 16. Available virtually or in-person for FREE! Register at: redcap.link/LynchSymposium…

There’s still time to join us for our <a href="/DanaFarber/">Dana-Farber</a> #LynchSyndrome Scientific Symposium all day Wed April 16. 

Available virtually or in-person for FREE! 

Register at: redcap.link/LynchSymposium…
CGA-IGC (@cgaigc) 's Twitter Profile Photo

📢#LynchSyndromeAwarenessDay may be over but the education continues ➡️Join our colleagues & friends from Dana-Farber & the wider #HereditaryGICancer community for this FREE #LynchSyndrome Scientific Symposium 🗓️Wed April 16 ⌚️9am-5pm ✍️redcap.link/LynchSymposium… 📍An impressive

Robert Hüneburg (@rhuneburg) 's Twitter Profile Photo

New in Nature Communications: IL-17A⁺NKp44(–) ILC3s accumulate in FAP duodenal tissue and may drive tumorigenesis via ROS-mediated DNA damage by our group. nature.com/articles/s4146…

Robert Hüneburg (@rhuneburg) 's Twitter Profile Photo

Finally out.... great cooperation with Carol Burke, Arjun Chatterjee and Cleveland Clinic assistance well as our German Consortium. Colonoscopy findings in CDH1 carriers from a multicenter international study. pubmed.ncbi.nlm.nih.gov/40323501/

Arjun Chatterjee (@chatterjee_md) 's Twitter Profile Photo

🚨 Our study: Largest International cohort of CDH1 pathogenic variant carriers 👫 we found ⬆️ adenoma detection rate (up to 48.6%) and early-onset CRC cases 🦀—even before age 50. This suggests ❓ need for earlier colorectal screening in this population. 📖